A cDNA clone for the Ya subunit of glutathione transferase from rat liver was constructed in E.coli. The clone hybridized to Ya and Yc subunit messenger RNAs. On the basis of experiments involving cell-free translation and hybridization to the cloned probe, it was shown that prototype inducers of cytochrome P-450 such as phenobarbitone and 3-methylcholanthrene as well as inhibitors such as CoCI2 and 3-amino-1,2,4-triazole enhanced the glutathione transferase (Ya+Yc) messenger RNA contents in rat liver. A comparative study with the induction of cytochrome P-450 (b+e) by phenobarbitone revealed that the drug manifested a striking increase in the nuclear pre-messenger RNAs for the cytochrome at 12 hr, but did not significantly affect the same in the case of glutathione transferase (Ya+Yc). 3-Amino-I, 2,4-triazole and CoCI2 blocked the phenobarbitone mediated increase in cytochrome P-450 (b+e) nuclear pre-messenger RNAs. These compounds did not significantly affect the glutathione transferase (Ya+Yc) nuclear pre-messenger RNA levels. The polysomal, poly (A)-containing messenger RNAs for cytochrome P-450 (b+e) increased by 12-15 fold after phenobarbitone administration, reached a maximum around 16hr and then decreased sharply. In comparison, the increase in the case of glutathione transferase (Ya+Yc) mesenger RNAs was sluggish and steady and a value of 3-4 fold was reached around 24 hr. Run-off transcription rates for cytochrome P-450 (b+e) increased by nearly 15 fold in 4 hr after phenobarbitone administration, whereas the increase for glutathione transferase (Ya+Yc) was only 2.0 fold. At 12 hr after the drug administration, the glutathione transferase (Ya+Yc) transcription rates were near normal. Administration of 3-amino-1,2,4-triazole and CoCI2 blocked the phenobarbitone-mediated increase in the transcription of cytochrome P-450 (b+e) messenger RNAs. These compounds at best had only marginal effects on the transcription of glutathione transferase (Ya+Yc) messenger RNAs. The half-life of cytochrome P-450 (b+e) messenger RNA was estimated to be 3-4 hr, whereas that for glutathione transferase (Ya+Yc) was found to be 8-9 hr. Administration of phenobarbitone enhanced the half-life of glutathione transferase (Ya+Yc) messenger RNA by nearly two fold. It is suggested that while transcription activation may play a primary role in the induction of cytochrome P-450 (b+e), the induction of glutathione transferase (Ya+Yc) may essentially involve stabilization of the messenger RNAs.
RNA contents in rat liver. A comparative study with the induction of cytochrome P-450 (b+e) by phenobarbitone revealed that the drug manifested a striking increase in the nuclear pre-messenger RNAs for the cytochrome at 12 hr, but did not significantly affect the same in the case of glutathione transferase (Ya+Yc). 3-Amino-I, 2,4-triazole and CoCI2 blocked the phenobarbitone mediated increase in cytochrome P-450 (b+e) nuclear pre-messenger RNAs. These compounds did not significantly affect the glutathione transferase (Ya+Yc) nuclear pre-messenger RNA levels. The polysomal, poly (A)-containing messenger RNAs for cytochrome P-450 (b+e) increased by 12-15 fold after phenobarbitone administration, reached a maximum around 16hr and then decreased sharply. In comparison, the increase in the case of glutathione transferase (Ya+Yc) mesenger RNAs was sluggish and steady and a value of 3-4 fold was reached around 24 hr. Run-off transcription rates for cytochrome P-450 (b+e) increased by nearly 15 fold in 4 hr after phenobarbitone administration, whereas the increase for glutathione transferase (Ya+Yc) was only 2.0 fold. At 12 hr after the drug administration, the glutathione transferase (Ya+Yc) transcription rates were near normal. Administration of 3-amino-1,2,4-triazole and CoCI2 blocked the phenobarbitone-mediated increase in the transcription of cytochrome P-450 (b+e) messenger RNAs. These compounds at best had only marginal effects on the transcription of glutathione transferase (Ya+Yc) messenger RNAs. The half-life of cytochrome P-450 (b+e) messenger RNA was estimated to be 3-4 hr, whereas that for glutathione transferase (Ya+Yc) was found to be 8-9 hr. Administration of phenobarbitone enhanced the half-life of glutathione transferase (Ya+Yc) messenger RNA by nearly two fold. It is suggested that while transcription activation may play a primary role in the induction of cytochrome P-450 (b+e), the induction of glutathione transferase (Ya+Yc) may essentially involve stabilization of
INTRODUCTION
Cytochrome P-450 and glutathione transferase constitute two major protein constituents of the drug metabolizing system (1, 2) . The induction of specific species of cytochrome P-450 in response to drug administration is a well known phenomenon. For example, phenobarbitone induces predominantly cytochrome P-450 b and e species in rat liver, whereas 3-methylcholanthrene induces cytochrome P-450 c and d species (3) (4) (5) . It has also been shown that these drugs act at the transcription level in this regard (6) (7) (8) (9) (14) (15) (16) .
In terms of the mechanism of action of foreign chemicals in inducing the cytochrome P-450 and glutathione transferase protein families, some interesting questions arise. In the case of cytochrome P-4 50, prototype drugs such as phenobarbitone and 3-methylcholanthrene induce distinctly different species at the transcription level. In the case of glutathione transferase, both the drugs seem to induce the same subunit species, although induction of additional drug-specific subunit species may also be involved. At this stage, it is not clear whether a transcription activation mechanism is responsible for the induction of the glutathione transferase subunits. Secondly, it has been shown in this laboratory that compounds such as CoCI2 and 3-amino-1,2,4-triazole block cytochrome P-450 gene transcription (9) . The effects of such inhibitors of cytochrome P-450 gene expression on the glutathione transferase system are not known. It is therefore of interest to examine the mechanism of induction of glutathione transferase in relation to that of cytochrome P-450, so that a possible explanation for the diverse effects of chemicals on the two gene systems can be attempted. In the present study, we have examined the mechanism of action of some of these chemicals on the expression of the glutathione transferase gene in rat liver, in relation to that of cytochrome P-450, using specific cloned cDNA probes.
EXPERIMENTAL PROCEDURES Treatment of animals:
Male albino rats (1O0g body weight) of the Institute strain were given single intraperitoneal injections of phenobarbitone (8mg/1 0Og), 3 -methylcholanthrene (4mg/1 0Og), 3 -amino-1,2,4-triazole (300mg/O00g), cordycepin (3mg/lOOg), actinomycin D (lOp g/ 1OOg) and CoCI2 (6mg/1O0g, subcutaneous), where indicated. In some experiments, multiple injections of some of the drugs were also given. The animals were killed by decapitation and livers processed for a variety of experiments.
Purification of glutathione transferase subunits:
Glutathione transferase species were purified essentially by a combination of the procedures described by Habig et al (17) and Hayes et al (11) . Briefly, the water extract of the livers was loaded on a DEAE-cellulose column and the escape was concentrated with ammonium sulphate and then loaded on a CM-Sephadex column. Four peaks of glutathione transferase activity were eluted using 0-80 mM NaCI gradient. Each peak was pooled, lyophilized and analyzed by 15% acrylamideurea gels (18) (22) . Translation of total polyribosomal poly (A)-containing RNA and the purified messenger RNA in the reticulocyte cell-free translation system (23) The translatable messenger RNA activity for glutathione transferase (Ya+Yc) was assessed using the reticulocyte cell-free system (23) . Poly(A)-containing RNA (8p g), isolated from rat livers given different treatments, was translated in a total volume of 100 p I in the presence of [35S] methionine. The translated products *were imunobound to glutathione transferase antibodies. The antigen-antibody complex was isolated using S.aureus cells and analyzed by urea-polyacrylamide gel (15%) electrophoresis and fluorography (18, 24) . Messenger RNA contents for glutathione transferase (Ya+Yc) as well as for cytochrome P-450 (b+e) were also quantified by hybridization to nick-translated probes employing dot blot and Northern blot hybridization procedures (25) . For this purpose, poly (A)-containing RNA from polyribosomes as well as total RNA from nuclei were -used. The isolation of nuclear RNA was by the procedure of Guertin et al (26) . The amounts of radioactivity quantified in the hybrids in these experiments were found to be proportional to the concentration ranges of RNA used.
Cell-free nuclear transcription: This was carried out again by the procedure of Guertin et al (26) and has been described (9) . The period was chosen, since the inhibitory effect of CoCI2 administration on cytochrome P-450 synthesis decreased with time and was much more pronounced at 12hr. There was nearly a 3-4 fold increase in the Ya subunit messenger RNA activity under all conditions of drug treatments. In addition, CoCI2 treatment resulted in a significant increase in the messenger RNA activity for Yc subunit as well (Fig 3, Table 1 ).
In order to quantify the messenger RNA content and the transcription rates of the glutathione transferase gene, we constructed a cloned cDNA probe. Clone pGT 19, on the basis of hybrid selection (data not presented) restriction mapping and partial sequencing (Fig 1) was characterized to be a Ya subunit clone from the complete sequencing data provided by Pickett et al (16) and Tu et al (27) . pGT 19 covered nearly 2/3 of the Ya subunit messenger RNA from the 3' end, having an extensive homology with that of the Yc subunit, and therefore the cloned DNA would hybridize to Ya and Yc subunit messenger RNAs. Northern blot analysis of the polyribosomal poly (A)-containing RNA isolated from rats treated with the different drugs under conditions described in Fig.3 revelaed that a 3-4 fold increase in Ya+Yc messenger RNA contents was achieved. The size of the messenger RNAs was around 900 nucleotides (Fig.4, Table 1 ). A dot blot analysis of the nuclear pre-m-RNAs, 12hr after a single injection of phenobarbitone also revealed a phenomenal increase in the case of cytochrome P-450(b+e) and this increase was blocked by the simultaneous administration of 3-amino-1,2,4-triazole or CoCI2. However, none of the drug treatments either alone or in the combination significantly changed the nuclear pre-mRNA contents for glutathione transferase (Ya+Yc) subunits (Fig.5) . (Fig.6 ).
The kinetics of messenger RNA induction as well as the status of nuclear pre-mRNAs are indicative of the transcription rates of the two gene systems. To confirm this, run-off transcription rates with nuclei isolated from rats given different drug treatments were assessed. The restilts presented in Table 2 indicate that 4hr after phenobarbitone administration there was nearly two-fold increase in glutathione transferase (Ya+Yc) messenger RNA transcription rates. However, with 3-amino-1,2,4-triazole and CoCI2 treatments the increase was only marginal. At 12hr after the drug treatments, phenobarbitone treatment at best elicited only about 30% increase in the glutathione transferase (Ya+Yc) messenger RNA transcription rates, whereas 3-amino-1,2,4-triazole and CoCI2 treatments had no effect. In contrast, phenobarbitone treatment elicited high levels of transcription rates for cytochrome P-450 (b+e) messenger RNA at both time intervals and 3-amino 1,2,4-triazole and CoCI2 treatments substantially blocked this increase. None of the treatments significantly affected the total transcription rates. Addition of a-amanitin (1 pg/ml) inhibited total transcription by around 50%, but the transcription of the two gene systems under consideration was inhibited by more than 95% (data not presented). 
DISCUSSION
Foreign chemicals induce enzymes in and outside the drug metabolizing pathway. The exact mechanism of this induction process has not been understood. However, in the case of cytochrome P-450, a specific transcriptional activation mechanism has been recognized (6) (7) (8) (9) . Strong evidences for the existence of a receptor for hydrocarbons such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene have been presented and the involvement of the inducer-receptor complex in activating specific cytochrome P-450 genes has been suggested (28) (29) (30) . In that light, the mechanism of action of inducers on the other enzymes of the drug metabolizing complex assumes importance, since it would raise questions on the specificity and multiplicity of receptors for an inducer, if a transcriptional activation mechanism is favoured in every case.
Phenobarbitone also induces specific cytochrome P-450 species by transcriptional activation (6, 7, 9) , although there is no definitive evidence for the mediation of a receptor. However, it is interesting to point out that whereas phenobarbitone and 3-methylcholanthrene induce distinctly different species of cytochrome P-450, they appear to induce the same subunit species (Ya+Yc) of glutathione transferese. In addition, inhibitors of cytochrome P-450 (b+e) messenger RNA synthesis such as CoCd2 and 3-amino-1,2,4-triazole actually enhance the glutathione transferase (Ya+Yc) messenger RNA levels.
The present studies reveal that while the dramatic increase in cytochrome P-450 (b+e) messenger RNA levels in response to a single injection of phenobarbitone can be explained on the basis of sustained high transcription rates of the genes concerned, the increase in glutathione transferase (Ya+Yc) messenger RNAs cannot be explained on this basis. Phenobarbitone does increase glutathione transferase (Ya+Yc) transcription rates by nearly 2-fold at early time intervals, but by 12hr the rates are only marginally higher than control, when the specific messenger RNA levels continue to increase. In addition, CoCd2 and 3-amino-1,2,4-triazole have only a marginal or no effect on transferase transcription rates, but nevertheless increase the specific messenger RNA contents.
Therefore, we have examined the possibility whether stabilization of glutathione transferase messenger RNAs by drug treatments can explain the increase in messenger RNA levels and enzyme protein content and activity. Measurement of half lives of protein and nucleic acids after blocking fresh translation and trans-cription with suitable inhibitors is a standard procedure, although the possibility of the inhibitors by themselves having an effect on the degradative process cannot be ruled out (31, 32) . We have used actinomycin D, an inhibitor of transcription and cordycepin, an RNA synthesis chain terminator to block fresh RNA synthesis. Earlier, it has been shown that cordycepin blocks the phenobarbitone-mediated messenger RNA induction for enzymes such epoxide hydratase, NADPH-cytochrome P-450 reductase and cytochrome P-450b (33) (34) (35) . On the basis that the transcription inhibitors exert similar effects in control and drug-treated rats, the results indicate that phenobarbitone administration enhances the half-life of glutathione transferase (Ya+Yc) messenger RNAs. Besides, the time course of induction of glutathione transferase (Ya+Yc) messenger RNAs after phenobarbitone administration (Fig.6) indicates that the messenger RNA half-life values obtained for the drug treated animals by the use of the transcription inhibitors (Fig.7) are approximately in the same range of values that can be calculated on the basis that the rate of approach to the new steady state is directly related to the degradation rate constant (36) . However, it has been possible to make half-life measurements only upto 8hr, since the transcription inhibitors were found to inhibit poly (A) -containing RNA synthesis maximally only upto this time point. Besides, the half-life values are a composite of two subunit messenger RNAs since the probes used hybridize to both the messenger RNAs having extensive homologies. Despite these limitations, the data clearly indicate stabilization as a major mechanism for the induction of transferase messenger RNAs, whereas, the increase in cytochrome P-450 messenger RNAs is essentially due to sustained high transcription rates. The list of messenger RNAs known to. be regulated atleast in part by turnover control includes hen ovalbumin, Xenopus vitellogenin, rat casein, dihydrofolate reductase and tubulin (36) . It is not clear whether the initial increase in the glutathione transferase transcription after phenobarbitone administration 'triggers' a cascade of events. We have, however, found that a wide variety of chemicals induce glutathione transferase (Ya+Yc) subunits and perhaps a generalized second messenger type response rather than an inducer-specific receptor mechanism is involved. It may also be pointed out that glutathione transferase is a major cytosolic protein in the normal rat liver unlike the induced cytochrome P-450 species which are present at very low levels in the untreated animal. Therefore, the glutathione transferase gene is perhaps transcribed at a high efficiency in the normal animal and the induction process should rather involve stabilization mechanisms.
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